BiotechTube
JRS Pharma

JRS Pharma

Rosenberg, Germany
jrspharma.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

JRS Pharma operates as a key supplier of functional excipients and coatings, positioning itself as an enabler for pharmaceutical and nutraceutical manufacturers. Its value proposition centers on a comprehensive product portfolio, global technical support, and formulation expertise, with a notable focus on replacing Titanium Dioxide (TiO2) through its VIVACOAT® line. As a member of the privately-held, globally active JRS Group, the company leverages a worldwide production network to offer stability, reliability, and security to its customers across the health science industry.

Drug Delivery

Technology Platform

Portfolio of functional excipients (binders, disintegrants, fillers) and ready-to-use film coating systems, with a flagship TiO2-replacement technology (VIVACOAT®). Supported by global technical service centers for formulation development and support.

Opportunities

The impending EU ban on Titanium Dioxide (E171) creates a substantial, immediate market for JRS Pharma's VIVACOAT® replacement coatings.
Additionally, the growing complexity of new drug molecules and the expansion of the global nutraceutical market drive demand for advanced formulation expertise and high-quality excipients.

Risk Factors

Key risks include intense competition in the excipient market, potential price pressure, and the regulatory risk associated with being a critical supplier to the highly regulated pharmaceutical industry.
The company is also exposed to raw material (e.g., cellulose) supply and price volatility.

Competitive Landscape

JRS Pharma competes in the global pharmaceutical excipients and coatings market against large, diversified chemical companies (e.g., DuPont, BASF, Ashland) and specialized ingredient suppliers (e.g., Roquette, DFE Pharma). Its differentiation lies in its specialized TiO2-free coatings, deep technical service, and the stability of being part of the global, family-owned JRS Group.

More companies in Drug Delivery & Formulation →More companies in Germany →